logo

CHE

Chemed
--
--(--)
Market Open: --
--
--(--)
Post-Market: --
Signals Analysis
Buy signal 1
Sell signal 3
Consensus Rating "Buy"
Bearish Engulfing
EPS Below Expectations
Revenue Below Expectations

Key Stats

0.0000DAY`S RANGE0.0000
0.000052 WK RANGE0.0000
0.0000
0.0000
--
--
--
--
--
--
--
--
--
--
--
--
--
--
0.0000
0.0000
0.0000
0.0000

About CHE

Chemed Corporation

A leading healthcare company that provides home healthcare and hospice services through its VITAS Healthcare and Roto-Rooter subsidiaries

Healthcare Providers and Services
Invalid Date
06/29/1982
New York Stock Exchange
15,695
12-31
Common stock
Suite 2600, 255 East Fifth Street, Cincinnati, Ohio 45202-4726
--
Chemed Corporation was incorporated in Delaware in 1970 as a subsidiary of W.R. Grace & Co., and until April 30, 1971, the company inherited the business of W.R. Grace & Co .'s Specialty Products Group. Until March 10, 1982, the company was a subsidiary of W.R. Grace & Co. In order to maximize shareholder value, Chemed purchased, operated and abandoned subsidiaries engaged in diversified businesses. The company operates a business based on decentralized management. The company has few centralized business functions (such as sales, marketing or purchasing). Chemed's corporate office management is involved and ultimately responsible for major capital allocation decisions, investment activities, financial reporting, taxation, legal and key management personnel selection for each operating business. Since its inception, the company has participated in 12 major acquisitions or divestitures of diversified business units. In 2015, Chemed operated in two divisions: Vitas Division (Vitas) and Roto-Rooter Division (Roto-Rooter). Vitas Healthcare provides hospice care to its patients through a system of doctors, registered nurses, home health aides, social workers, clergy and volunteers. Roto-Rooter provides plumbing and plumbing cleaning services to residential and commercial customers.

Company Financials

EPS

CHE has released its 2025 Q1 earnings. EPS was reported at 5.63, versus the expected 5.55, beating expectations. The chart below visualizes how CHE has performed over recent quarters, highlighting trends in earnings surprises.

Revenue & Expenses

CHE has released its 2025 Q1 earnings report, with revenue of 646.94M, reflecting a YoY change of 9.79%, and net profit of 71.76M, showing a YoY change of 10.37%. The Sankey diagram below clearly presents CHE's revenue sources and cost distribution.

Forecast

Wall Street Opinions

Price Target

Volume Profile

Trade Flow Insight

Seasonals

Community Forum

Loading...

Related News

No articles available

Related Symbols

You can ask Aime